CN105476013A - 一种花青素防癌口服液及其制备方法 - Google Patents
一种花青素防癌口服液及其制备方法 Download PDFInfo
- Publication number
- CN105476013A CN105476013A CN201511004394.9A CN201511004394A CN105476013A CN 105476013 A CN105476013 A CN 105476013A CN 201511004394 A CN201511004394 A CN 201511004394A CN 105476013 A CN105476013 A CN 105476013A
- Authority
- CN
- China
- Prior art keywords
- anthocyanidin
- oral liquid
- preventing cancer
- preparation
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 44
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 42
- 201000011510 cancer Diseases 0.000 title claims abstract description 38
- 229930014669 anthocyanidin Natural products 0.000 title claims abstract description 37
- 150000001452 anthocyanidin derivatives Chemical class 0.000 title claims abstract description 37
- 235000008758 anthocyanidins Nutrition 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 240000006365 Vitis vinifera Species 0.000 claims abstract description 16
- 235000014787 Vitis vinifera Nutrition 0.000 claims abstract description 16
- 244000241872 Lycium chinense Species 0.000 claims abstract description 14
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 14
- 240000004922 Vigna radiata Species 0.000 claims abstract description 13
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims abstract description 13
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims abstract description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 9
- 230000008569 process Effects 0.000 claims abstract description 8
- 229910001220 stainless steel Inorganic materials 0.000 claims abstract description 8
- 239000010935 stainless steel Substances 0.000 claims abstract description 8
- 238000009835 boiling Methods 0.000 claims abstract description 7
- 235000004976 Solanum vernei Nutrition 0.000 claims description 16
- 241000352057 Solanum vernei Species 0.000 claims description 16
- 240000001890 Ribes hudsonianum Species 0.000 claims description 15
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 15
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 15
- 238000001556 precipitation Methods 0.000 claims description 8
- 238000007789 sealing Methods 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 230000014759 maintenance of location Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000003345 natural gas Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 230000001093 anti-cancer Effects 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 6
- 230000006378 damage Effects 0.000 abstract description 5
- 208000027418 Wounds and injury Diseases 0.000 abstract description 4
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 241000700605 Viruses Species 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 208000014674 injury Diseases 0.000 abstract description 3
- 230000036772 blood pressure Effects 0.000 abstract description 2
- 230000035622 drinking Effects 0.000 abstract description 2
- 244000017020 Ipomoea batatas Species 0.000 abstract 1
- 235000002678 Ipomoea batatas Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 239000008213 purified water Substances 0.000 abstract 1
- 239000006228 supernatant Substances 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 15
- 239000000463 material Substances 0.000 description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 235000001465 calcium Nutrition 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 235000001055 magnesium Nutrition 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 241000383638 Allium nigrum Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000007686 potassium Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 2
- 240000002234 Allium sativum Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960004544 cortisone Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000004611 garlic Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000014786 phosphorus Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 235000016804 zinc Nutrition 0.000 description 2
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 229940029982 garlic powder Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001535 kindling effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明提供一种花青素防癌口服液及其制备方法,属于功能性食品领域,该花青素防癌口服液包括以下重量份数的原料,紫薯150g,绿豆50g,黑加仑葡萄干50g,黑芝麻50g,枸杞子50g,纯净水3L,该花青素防癌口服液制备方法采用不锈钢锅煮沸10分钟,沉淀后留取上清液,分装,冰箱保存。本发明工艺成熟,制作成本较低,改善了服用口味,长期饮用本发明制出的口服液能使人体具有抗癌能力,增强免疫力,无任何副作用和不良反应,能防止外界病毒对人体造成的伤害,同时还能起到降压、降血脂的功效,防癌效果显著。
Description
技术领域
本发明属于功能性食品领域,尤其涉及一种花青素防癌口服液及其制备方法。
背景技术
花青素是一种水溶性色素,可以随着细胞液的酸碱改变颜色。细胞液呈酸性则偏红,细胞液呈碱性则偏蓝。自然界有超过300种不同的花青素。他们来源于不同种水果和蔬菜如紫薯、越橘、酸果蔓、蓝莓、葡萄、接骨木红、黑加仑、紫胡罗卜和红甘蓝、颜色从红到蓝。
花青素是一种强有力的抗氧化剂,它能够保护人体免受一种叫做自由基的有害物质的损伤,花青素能为人体带来多种益处。:1.有助于预防多种与自由基有关的疾病,包括癌症、心脏病、过早衰老和关节炎;2.通过防止应激反应和吸烟引起的血小板凝集来减少心脏病和中风的发生;3.增强免疫系统能力来抵御致癌物质4.降低感冒的次数和缩短持续时间;5.具有抗突变的功能从而减少致癌因子的形成6.具有抗炎功效,因而可以预防包括关节炎和肿胀在内的炎症;7.缓解花粉病和其它过敏症8.增强动脉、静脉和毛细血管弹性;9.保护动脉血管内壁,等等。
癌症也是因自由基毁坏遗传物质(DNA)而导致的。借着保护遗传物质,花青素(Anthocyanosides)将能间接的保护我们对抗癌症。虽然是长期的,但是花青素(Anthocyanosides)确有间接的保护作用。而花青素(Anthocyanosides)清除自由基的功效,亦可让癌细胞无法顺利扩散,借此保护更多健康的细胞免于被癌细胞侵蚀。另一方面有些癌症透过溶解组织和细胞的物质形成肿瘤,这些癌细胞产生溶解脢和蛋白脢,而花青素(Anthocyanosides)能保护蛋白质不受蛋白脢的影响。像是乳腺癌的致病机制便是如此,因此服用花青素(Anthocyanosides)对于乳腺癌的发展会有很好的抑制作用。
中国专利公开号为CN104585649A,发明创造的名称为一种生物活性参灵黑蒜口服液及其制备方法,大蒜在高温高湿条件下,利用独特工艺发酵为熟化黑蒜,它在保持了大蒜原有成份的基础上,其抗氧化能力和活性化效力提高了数十倍。黑蒜粉(70%)与人参皂苷RH2干粉(10%)、灵芝孢子粉(10%)、松花粉(5%)、葛根干粉(5%)经过超微粉碎、反复煎煮和过滤去渣、蒸馏浓缩、乙醇浸提、乙醇液减压浓缩、配制和定容、包装灭菌等工艺步骤,制成成品,制成的产品在防治癌症,糖尿病,心脑血管疾病更具有方向性和广泛性。
但是,现有的防癌口服液存在着原料价格较高,工艺复杂,服用口味不佳,防癌效果不理想,经济效益低的问题。
因此,发明一种花青素防癌口服液及其制备方法显得非常必要。
发明内容
为了解决上述技术问题,本发明提供一种花青素防癌口服液及其制备方法,以解决现有的防癌口服液存在着原料价格较高,工艺复杂,服用口味不佳,防癌效果不理想,经济效益低的问题。一种花青素防癌口服液包括以下重量份数的原料,紫薯150g,绿豆50g,黑加仑葡萄干50g,黑芝麻50g,枸杞子50g,纯净水3L。
优选地,包括以下重量份数的原料,紫薯切薄片100g,绿豆20g,黑加仑葡萄干20g,黑芝麻20g,枸杞子20g,纯净水2L。
优选地,包括以下重量份数的原料,紫薯切薄片100g-200g,绿豆20g-80g,黑加仑葡萄干20g-80g,黑芝麻20g-80g,枸杞子20g-80g,纯净水2L-5L。
一种花青素防癌口服液制备方法具体包括以下步骤:
步骤一:制备前的原料去除杂质,清洗干净,紫薯切薄片,按比例配置;
步骤二:将步骤一准备的原料放入不锈钢锅加入纯净水,煮沸10分钟;
步骤三:将步骤二煮沸溶液冷却沉淀5至15分钟,沉淀上方出现清液;
步骤四:采用带有滤网吸管吸取步骤三中清液,分装至容器并密封;
步骤五:采用密封后的容器放入冰箱2℃至100℃储存。
优选地,在步骤二中,所述的煮沸之前文火加热10至25分钟。
优选地,在步骤二中,所述的煮沸在标准大气压下,煮沸温度为100℃。
优选地,在步骤二中,所述的煮沸采用电磁炉或者天然气加热。
优选地,在步骤四中,所述的滤网吸管采用的滤网为不锈钢滤网,滤网网孔为30目至50目。
优选地,在步骤四中,所述的密封过程采用无菌密封。
优选地,在步骤五中,所述的冰箱储存时间不超过3天至6天。
紫薯根据最近功效检测证明含有丰富的锌、钙、镁等多种人体有益元素,特别含有最佳值的硒元素.硒元素巳被世界医学界称为超级巨星、生命火种和抗癌之王.其抗癌功能在所有食品中独占第一.长期食用,具有提高人体免疫力,抗癌防癌、软化血管、降血压、降血脂、补钙、健身、美容等保健作用。
绿豆经典中医认为:可消肿通气,清热解毒。将生绿豆研碎绞成汁水吞服,可医治丹毒,烦热风疹,药石发动,热气奔腾。补肠胃。可治伤风头痛,消除呕吐。经常吃,补益元气,和调五脏,安神,通行十二经脉,除去皮屑,滋润皮肤,煮汁汤可解渴,解一切药草、牛马、金石之毒。
黑加仑葡萄干含有非常丰富的维生素C、磷、镁、钾、钙、花青素、酚类物质,尤其是维生素C的含量高于绝大多数水果,比苹果、桃和葡萄的含量要高出几倍至上百倍;含有较高比例的矿物质钙、镁、钠、钾、铁、磷和锌等,其中钙的含量为水果之冠,对幼儿及老年补充钙质十分合适。黑加仑葡萄干中含有相当多的钾盐和镁盐,钾盐的主要功能是加强肌肉的兴奋性,稳定心肌肉细胞膜,改律失常;镁盐对高血压和心肌梗塞有一定的预防和治疗作用,人们脑力或体力超负荷时,进入血液中的一种苛尔蒙可的松物质可以造成心肌坏死,经医学专家临床证明,黑加仑葡萄干饮用含钾和镁的饮料可以可的松的生成,故对心脏病患者有一定的保健作用。黑加仑果实中含有较高量的生物类黄酮,能有效降低动脉硬化程度,使变脆的血管软化变薄,改善血管的通透性,能预防动脉粥样硬,作为延缓衰老的物质,具有阻断亚硝胺的生成作用,具有抗氧化作用,而且对抗坏血酸也有增效作用。
研究人员从黑加仑籽中提取的天然油脂中突破性地发现了α-亚麻酸和γ-亚麻酸,这两种亚麻酸不但具有血小板聚集、降低血压、软化血管、降低血脂、预防和治疗心脏血管疾病的作用,而且还具有较强的抗癌、防癌(乳腺癌、直肠癌等)作用,对防止肿瘤发生,延缓衰老,调节人体生理功能,增加免疫能力有显著功效,同时还有美容、减肥作用。
《本草纲目》称:“服黑芝麻百日能除一切痼疾。一年身面光泽不饥,二年白发返黑,三年齿落更出”。黑芝麻含的维生E占居植物性食品之首,而维生素E能促进细胞分裂,推迟细胞衰老,常用之,可抵消或中和细胞内衰老物质“游离基”的积累,起到抗衰老和延年益寿的作用。据科学家实验表明,维生素E可使实验动物的寿命延长15%~75%。
枸杞子对免疫功能的影响:有增强非特异性免疫作用,小鼠灌服枸杞子水提取物或肌注醇提取物和枸杞多糖,均有提高巨噬细胞的吞噬功能,增强血清溶菌酶的作用,提高血清中抗绵羊红细胞抗体的效价,还能增加鼠脾脏中抗绵羊红细胞的抗体形成细胞的数量。体外试验表明,枸杞子对人胃腺癌KATo-Ⅲ细胞和人宫颈癌Hela细胞均有明显抑制作用,其作用机理主要表现在抑制细胞DNA合成,干扰细胞分裂,细胞再殖能力下降。
与现有技术相比,本发明具有如下有益效果:由于本发明的一种花青素防癌口服液及其制备方法广泛应用于功能性食品技术领域。本发明工艺成熟,制作成本较低,改善了服用口味,长期饮用本发明制出的口服液能使人体具有抗癌能力,增强免疫力,无任何副作用和不良反应,能防止外界病毒对人体造成的伤害,同时还能起到降压、降血脂的功效,防癌效果显著。
附图说明
图1是花青素防癌口服液制备方法流程图。
具体实施方式
以下结合附图对本发明做进一步描述:
图中:
如附图1所示
一种花青素防癌口服液包括以下重量份数的原料,紫薯150g,绿豆50g,黑加仑葡萄干50g,黑芝麻50g,枸杞子50g,纯净水3L。
优选地,包括以下重量份数的原料,紫薯切薄片100g,绿豆20g,黑加仑葡萄干20g,黑芝麻20g,枸杞子20g,纯净水2L。
优选地,包括以下重量份数的原料,紫薯切薄片100g-200g,绿豆20g-80g,黑加仑葡萄干20g-80g,黑芝麻20g-80g,枸杞子20g-80g,纯净水2L-5L。
一种花青素防癌口服液及其制备方法具体包括以下步骤:
S101:制备前的原料去除杂质,清洗干净,紫薯切薄片,按比例配置;
S102:将S101准备的原料放入不锈钢锅加入纯净水,煮沸10分钟;
S103:将S102煮沸溶液冷却沉淀5至15分钟,沉淀上方出现清液;
S104:采用带有滤网吸管吸取S103中清液,分装至容器并密封;
S105:采用密封后的容器放入冰箱2℃至100℃储存。
优选地,在S102中,所述的煮沸之前文火加热10至25分钟。
优选地,在S102中,所述的煮沸在标准大气压下,煮沸温度为100℃。
优选地,在S102中,所述的煮沸采用电磁炉或者天然气加热。
优选地,在S104中,所述的滤网吸管采用的滤网为不锈钢滤网,滤网网孔为30目至50目。
优选地,在S104中,所述的密封过程采用无菌密封。
优选地,在S105中,所述的冰箱储存时间不超过3天至6天
具体实例
1、制备前的原料去除杂质,清洗干净,紫薯切薄片,按紫薯150g,绿豆50g,黑加仑葡萄干50g,黑芝麻50g,枸杞子50g,纯净水3L配备;
2、将配备原料准备的原料放入不锈钢锅加入纯净水,煮沸10分钟;
3、将煮沸溶液冷却沉淀15分钟,沉淀上方出现清液;;
4、采用带有滤网吸管吸取步骤三中清液,分装至容器并密封;
5、采用密封后的容器放入冰箱2℃至100℃储存。
验证结果表明,本发明工艺成熟,制作成本较低,改善了服用口味,长期饮用本发明制出的口服液能使人体具有抗癌能力,增强免疫力,无任何副作用和不良反应,能防止外界病毒对人体造成的伤害,同时还能起到降压、降血脂的功效,防癌效果显著。
为了验证该发明的功能性作用,针对癌症患者,在遵守伦理道德的原则下我们实施了三组不同癌症患者的临床实验,在找出试食花青素防癌口服液志愿者后,向他们说明了本次实验的意图,在得到他们理解的基础上,开始了为期三个月的实验,本次实验依据赫尔辛基宣言的规定进行,最终结论该发明是可以成为安全性高预防癌症的食品。
利用本发明所述的技术方案,或本领域的技术人员在本发明技术方案的启发下,设计出类似的技术方案,而达到上述技术效果的,均是落入本发明的保护范围。
Claims (10)
1.一种花青素防癌口服液,其特征在于,该花青素防癌口服液包括以下重量份数的原料,紫薯150g,绿豆50g,黑加仑葡萄干50g,黑芝麻50g,枸杞子50g,纯净水3L。
2.如权利要求1所述的花青素防癌口服液,其特征在于,包括以下重量份数的原料,紫薯切薄片100g,绿豆20g,黑加仑葡萄干20g,黑芝麻20g,枸杞子20g,纯净水2L。
3.如权利要求1所述的花青素防癌口服液,其特征在于,包括以下重量份数的原料,紫薯切薄片100g-200g,绿豆20g-80g,黑加仑葡萄干20g-80g,黑芝麻20g-80g,枸杞子20g-80g,纯净水2L-5L。
4.一种花青素防癌口服液制备方法,其特征在于,该种花青素防癌口服液制备方法具体包括以下步骤:
步骤一:制备前的原料去除杂质,清洗干净,紫薯切薄片,按比例配置;
步骤二:将步骤一准备的原料放入不锈钢锅加入纯净水,煮沸10分钟;
步骤三:将步骤二煮沸溶液冷却沉淀5至15分钟,沉淀上方出现清液;
步骤四:采用带有滤网吸管吸取步骤三中清液,分装至容器并密封;
步骤五:采用密封后的容器放入冰箱2℃至100℃储存。
5.如权利要求4所述的花青素防癌口服液制备方法,其特征在于,在步骤二中,所述的煮沸之前文火加热10至25分钟。
6.如权利要求4所述的花青素防癌口服液制备方法,其特征在于,在步骤二中,所述的煮沸在标准大气压下,煮沸温度为100℃。
7.如权利要求4所述的花青素防癌口服液制备方法,其特征在于,在步骤二中,所述的煮沸采用电磁炉或者天然气加热。
8.如权利要求4所述的花青素防癌口服液制备方法,其特征在于,在步骤四中,所述的滤网吸管采用的滤网为不锈钢滤网,滤网网孔为30目至50目。
9.如权利要求4所述的花青素防癌口服液制备方法,其特征在于,所述的密封过程采用无菌密封。
10.如权利要求4所述的花青素防癌口服液制备方法,其特征在于,所述的冰箱储存时间不超过3天至6天。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511004394.9A CN105476013A (zh) | 2015-12-29 | 2015-12-29 | 一种花青素防癌口服液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511004394.9A CN105476013A (zh) | 2015-12-29 | 2015-12-29 | 一种花青素防癌口服液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105476013A true CN105476013A (zh) | 2016-04-13 |
Family
ID=55663586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511004394.9A Pending CN105476013A (zh) | 2015-12-29 | 2015-12-29 | 一种花青素防癌口服液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105476013A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100345A (zh) * | 2009-12-17 | 2011-06-22 | 孟凡忠 | 一种以紫薯为主要原料的保健休闲食品 |
CN102579893A (zh) * | 2011-01-09 | 2012-07-18 | 曹文桂 | 黄芪养生粥 |
-
2015
- 2015-12-29 CN CN201511004394.9A patent/CN105476013A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102100345A (zh) * | 2009-12-17 | 2011-06-22 | 孟凡忠 | 一种以紫薯为主要原料的保健休闲食品 |
CN102579893A (zh) * | 2011-01-09 | 2012-07-18 | 曹文桂 | 黄芪养生粥 |
Non-Patent Citations (2)
Title |
---|
凌文华等: "《植物花色苷》", 30 September 2009 * |
杨月欣等: "《营养功能成分应用指南》", 30 June 2011 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103392887A (zh) | 金银花保健茶 | |
CN104845858A (zh) | 一种无醇枸杞果酒的生产工艺 | |
CN107996757A (zh) | 一种降血压、降血糖、降血脂、降胆固醇的保健饮品及其制备方法 | |
CN104171189A (zh) | 一种人参虫草保健茶及其制备方法 | |
CN104489539A (zh) | 一种营养蜜番茄罐头的加工工艺 | |
KR101348311B1 (ko) | 마늘 발효액 및 그 제조방법 | |
CN106954851A (zh) | —种三叶青食品 | |
CN109170014A (zh) | 一种石斛保健茶及其制备方法 | |
CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
CN107557204B (zh) | 一种混酿荔枝玫瑰酒及其制备方法 | |
CN107557254B (zh) | 一种荔枝玫瑰酒和制备方法及补益气血与抗氧化应用 | |
CN107319540A (zh) | 一种含浒苔改善糖尿病的保健食品及其制备方法 | |
CN106509894A (zh) | 一种辣木三七含片及其制备工艺 | |
KR102452902B1 (ko) | 한약재 토종 약술 및 그 제조방법 | |
CN103431100B (zh) | 一种具有保健养生作用的芦笋饮料 | |
CN105380041A (zh) | 一种猕猴桃山茱萸枸杞保健饮料的制备工艺 | |
KR20120008263A (ko) | 천년초 선인장 액상 음료의 제조방법 | |
CN104273261A (zh) | 延年益寿养生中药茶饮品及制备方法 | |
CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
CN103719431A (zh) | 一种余甘子解酒茶及其制备方法 | |
CN104473283B (zh) | 一种玫瑰姜醋饮料及其制备方法 | |
CN105476013A (zh) | 一种花青素防癌口服液及其制备方法 | |
CN105341279A (zh) | 一种降压养生茶及其制作方法 | |
KR101327802B1 (ko) | 장어 발효액 및 그 제조방법 | |
CN101586071A (zh) | 罗汉果醋 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160413 |